.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
US Army
Harvard Business School
Medtronic
Argus Health
Teva
Julphar
Federal Trade Commission
Healthtrust

Generated: September 23, 2017

DrugPatentWatch Database Preview

Drug Master Files for: rifaximin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
12352III2/6/1997PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTDRIFAXIMIN
15635AII9/20/2001FIS FABBRICA ITALIANA SINTETICI SPARIFAXIMIN
17150AII2/10/2004SANOFI AVENTIS SPARIFAXIMIN
17974AII12/14/2004OLON SPARIFAXIMIN
20436AII3/31/2007LUPIN LTD INDIARIFAXIMIN
28906AII2/3/2015RAKS PHARMA PVT LTDRIFAXIMIN
29449AII6/10/2015MSN LABORATORIES PRIVATE LTDRIFAXIMIN [ROUTE CODE RFB]
29359AII5/11/2015SEQUENT SCIENTIFIC LTDRIFAXIMIN
28096AII3/28/2014MSN LABORATORIES PRIVATE LTDRIFAXIMIN [ROUTE CODE RX]
28097AII3/28/2014MSN LABORATORIES PRIVATE LTDRIFAXIMIN [ROUTE CODE RFa]
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Dow
Covington
McKesson
QuintilesIMS
US Department of Justice
Colorcon
Argus Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot